Functional Annotation Report: fabB (Q88FC3, PP_4175) — β-Ketoacyl-[ACP] Synthase I of Pseudomonas putida KT2440

Summary

The gene fabB (ordered locus PP_4175; UniProt Q88FC3) of Pseudomonas putida strain KT2440 (ATCC 47054 / DSM 6125 / NCIMB 11950) encodes β-ketoacyl-[acyl-carrier-protein] synthase I (KAS I; also called 3-oxoacyl-[ACP] synthase 1 or β-ketoacyl-ACP synthase I; EC 2.3.1.41). This is a soluble, cytoplasmic condensing enzyme of the type II (dissociated) fatty acid synthase (FAS II) system, the bacterial machinery that builds membrane fatty acids from malonyl-ACP building blocks. The identity is secure: the 406-residue Q88FC3 protein is 67.3% identical to the biochemically defined Escherichia coli FabB, belongs to the thiolase-like superfamily / β-ketoacyl synthase family (InterPro IPR000794, IPR018201, IPR014030/031, IPR020841), and retains every catalytic residue of the characterized enzyme. All literature reviewed converges on the same gene family and organism group; this is the correct target, not a same-symbol homolog from an unrelated gene.

The primary catalytic function of FabB is a decarboxylative Claisen (Claisen-type) condensation: it elongates an ACP-bound acyl chain by two carbons per cycle. In three chemical steps, it (1) transfers a growing acyl primer from ACP onto its active-site cysteine, (2) decarboxylates malonyl-ACP to a reactive carbanion/enolate, and (3) condenses that nucleophile with the enzyme-bound acyl group to form a new carbon–carbon bond, releasing β-ketoacyl-ACP, CO₂, and holo-ACP. Catalysis depends on a Cys-His-His triad (in Q88FC3: Cys161, His296, His331) supported by Asp304/Glu307/Lys326 — all strictly conserved. The two-histidine architecture distinguishes elongation condensing enzymes (FabB/FabF) from the initiation enzyme FabH and defines sensitivity to the natural-product inhibitors cerulenin and thiolactomycin.

FabB's specialized, non-redundant biological role is as the committed enzyme of the anaerobic (oxygen-independent) unsaturated fatty acid (UFA) pathway. Working downstream of the dehydratase/isomerase FabA, FabB preferentially elongates the cis-3-decenoyl-ACP intermediate, channeling carbon flux toward the membrane unsaturated fatty acids palmitoleate (16:1) and cis-vaccenate (18:1) and thereby setting membrane fluidity. In Pseudomonas, fabA and fabB form a fabAB operon and their loss causes UFA auxotrophy. A notable distinction from the E. coli paradigm is that in P. putida, FabB is bifunctional: it both initiates FAS (decarboxylating malonyl-ACP and condensing the resulting acetyl-ACP with malonyl-ACP) and elongates the chain, whereas E. coli FabB performs elongation only. The enzyme carries out its function in the cytoplasm/cytosol as part of the soluble FAS II enzyme ensemble that shuttles substrates via the acyl carrier protein AcpP.

Key Findings

Finding 1 — Q88FC3 is β-ketoacyl-ACP synthase I (KAS I, EC 2.3.1.41), an FAS II elongation condensing enzyme

Q88FC3 is a 406-amino-acid protein of P. putida KT2440 that is 67.3% identical (272 of 404 aligned positions) to the well-characterized E. coli FabB (P0A953) by global Needleman-Wunsch alignment. It belongs to the thiolase-like superfamily / β-ketoacyl synthase family, carrying the diagnostic InterPro domains IPR000794 (β-ketoacyl synthase), IPR018201 (ketoacyl synthase active site), and IPR014030/IPR014031 (N- and C-terminal ketoacyl synthase domains). Functionally, KAS I performs the elongation Claisen condensation of FAS II: it takes a growing acyl-ACP primer and condenses it with malonyl-ACP, extending the chain by two carbons per cycle and producing β-ketoacyl-ACP + CO₂ + holo-ACP.

The condensing enzymes of type II FAS are established drug targets. As stated in PMID: 11050088: "The beta-ketoacyl-acyl carrier protein (ACP) synthases are key regulators of type II fatty acid synthesis and are the targets for two natural products, thiolactomycin (TLM) and cerulenin." Independent work reiterates the central role of this enzyme in bacteria: "beta-ketoacyl acyl carrier protein synthase I (KAS I) is member of the condensing enzyme family, which is a key catalyst in bacterial fatty acid biosynthesis" (PMID: 26292066). Together with the sequence and domain analysis, these establish Q88FC3 as an authentic KAS I/FabB.

Finding 2 — Conserved Cys-His-His catalytic triad and a three-step condensation mechanism

The catalytic machinery of FabB is fully conserved in Q88FC3. In E. coli KAS I, mutagenesis dissected the reaction into three chemical steps and identified the essential residues. As described in PMID: 11502177: "beta-Ketoacyl-[acyl carrier protein (ACP)] synthase forms new carbon-carbon bonds in three steps: transfer of an acyl primer from ACP to the enzyme, decarboxylation of the elongating substrate and its condensation with the acyl primer substrate." The same study established the division of labor among active-site residues: "The active site Cys-163 is not required for decarboxylation, whereas His-298 and His-333 are indispensable." Thus Cys163 is the acyl-accepting nucleophile, and the two histidines drive decarboxylation of malonyl-ACP; Asp306, Glu309, and Lys328 provide supporting roles.

Mapping these positions onto Q88FC3 by alignment shows every catalytic residue is conserved: E. coli Cys163 → P. putida Cys161, His298 → His296, His333 → His331, Asp306 → Asp304, Glu309 → Glu307, and Lys328 → Lys326. The two-histidine (His-His-Cys) active-site architecture distinguishes FabB/FabF elongation enzymes from the His-Asn-Cys triad of the initiation enzyme FabH and governs inhibitor binding. Per PMID: 11050088, the structural analysis was "illustrating that the two-histidine active site architecture is critical to protein-antibiotic interaction." The conservation of this complete triad in Q88FC3 strongly implies an identical catalytic mechanism.

Finding 3 — FabB is the committed enzyme of the anaerobic unsaturated fatty acid pathway

Bacteria that lack a desaturase (including E. coli and Pseudomonas) make unsaturated fatty acids anaerobically during elongation. The dehydratase/isomerase FabA introduces a cis double bond at the C10 stage (converting trans-2-decenoyl-ACP to cis-3-decenoyl-ACP), but this branch point is only committed to the UFA pathway when a condensing enzyme with the right specificity elongates the cis-3 intermediate. FabB provides that specificity. As reported in PMID: 8910376: "the channeling of intermediates toward unsaturated fatty acid synthesis by FabB was attributed to the affinity of the condensing enzyme for cis-decenoyl-ACP." FabB therefore elongates the cis-3-decenoyl-ACP branch onward to palmitoleate (16:1) and cis-vaccenate (18:1), the dominant membrane UFAs.

Genetic evidence in Pseudomonas directly ties FabB to UFA biosynthesis. In P. aeruginosa, "Chromosomal fabA and fabB mutants were isolated; the mutants were auxotrophic for unsaturated fatty acids" (PMID: 9286984) — i.e., without FabB, the cell cannot make UFAs and must import them. The same study established the genomic linkage: "fabA and fabB are cotranscribed and most probably form a fabAB operon," physically and transcriptionally coupling the double-bond-introducing enzyme (FabA) to the committing elongation enzyme (FabB). This operon organization in Pseudomonas underscores that FabB's specialized role is UFA commitment.

Finding 4 — In P. putida, FabB is bifunctional: it both initiates and elongates fatty acid synthesis

A key departure from the E. coli textbook picture is that P. putida FabB does not merely elongate — it can also initiate FAS. In P. putida F1 (a close relative of KT2440), the two FabH (KAS III) initiation paralogs are individually dispensable, and FabB was shown to prime the pathway. The primary study states directly: "we report that Pseudomonas putida F1 β-ketoacyl-ACP synthase I (FabB), in addition to playing a key role in fatty acid elongation, also initiates FAS in vivo" (PMID: 38335573). The biochemical basis is described in the same paper: "P. putida FabB decarboxylates malonyl-ACP and condenses the acetyl-ACP product with malonyl-ACP for initiation of FAS." This means FabB can generate its own acetyl-ACP primer in situ and start the first condensation — an activity E. coli FabB lacks.

In the broader regulatory network (defined largely in the enterobacterial paradigm), fabB is transcriptionally controlled to balance membrane lipid composition. It is positively regulated by FadR: "fabB, a second unsaturated fatty acid biosynthetic gene, is also positively regulated by FadR" (PMID: 11566998). It is repressed by FabR in response to the unsaturated:saturated acyl-ACP ratio (PMID: 19854834), and FabB's productive interaction with the acyl carrier protein AcpP has been structurally defined and shown to shape the lipid profile (PMID: 31209348). While these regulatory details derive from E. coli, they illustrate how fabB output is tuned to membrane physiology.

Finding 5 — Database curation confirms cytoplasmic KAS I with a specific UFA-elongation reaction (and flags a spurious kinase annotation)

UniProt curation of Q88FC3 independently supports the functional assignment. It curates the general elongation reaction "a fatty acyl-[ACP] + malonyl-[ACP] + H⁺ = a 3-oxoacyl-[ACP] + holo-[ACP] + CO₂" and, importantly, the committed UFA-elongation reaction "(3Z)-decenoyl-[ACP] + malonyl-[ACP] + H⁺ = 3-oxo-(5Z)-dodecenoyl-[ACP] + holo-[ACP] + CO₂" — precisely the reaction that channels flux from FabA's cis-3-decenoyl-ACP intermediate into the unsaturated branch. The subcellular location is annotated as Cytoplasm (GO:0005829 cytosol), and the pathway is fatty acid biosynthesis (GO:0006633).

Cross-strain conservation analysis performed in this investigation validates the transfer of the experimental P. putida F1 data to KT2440: Q88FC3 (406 aa) is 98.3% identical to P. putida NBRC 14164 FabB and 92–99% identical to FabB across the P. putida / P. monteilii / P. mosselii group. The experimentally characterized F1 enzyme (PMID: 38335573) is therefore effectively the same protein as KT2440 Q88FC3, so its bifunctional initiation+elongation phenotype applies directly.

Annotation caveat: UniProt Q88FC3 also carries automated "Kinase"/"ATP-binding" keywords (GO:0016301, GO:0005524). These are biologically incorrect for a KAS I condensing enzyme — FabB uses no ATP and has no kinase activity — and appear to be a pipeline/electronic-annotation artifact. This is a concrete example of why database annotations should be checked against primary literature.

Finding 6 — Consolidated annotation

Integrating all five lines of evidence yields a confident annotation: fabB (Q88FC3, PP_4175) encodes the cytoplasmic KAS I of P. putida KT2440 that commits FAS II flux to unsaturated fatty acids and, uniquely, can both initiate and elongate the pathway. The supporting pillars are: (1) 67.3% identity to E. coli FabB with all six catalytic residues conserved (Cys161/His296/His331/Asp304/Glu307/Lys326); (2) the three-step transacylation→decarboxylation→condensation mechanism with the His-His-Cys triad (PMID: 11502177, PMID: 11050088); (3) the committed-UFA role via affinity for cis-3-decenoyl-ACP, with fabA/fabB required for UFA in Pseudomonas (PMID: 8910376, PMID: 9286984); (4) bifunctional initiation+elongation in P. putida (PMID: 38335573); and (5) UniProt curation of cytoplasmic localization plus the specific (3Z)-decenoyl-ACP reaction, with ~98% cross-strain identity validating transfer of the F1 data.

Mechanistic Model / Interpretation

The reaction FabB catalyzes

FabB carries out one turn of the FAS II elongation cycle — a decarboxylative Claisen condensation on ACP-tethered substrates:

  Acyl(Cₙ)-ACP  +  Malonyl-ACP  +  H⁺
        │
        ▼   (FabB: Cys161 nucleophile; His296/His331 drive decarboxylation)
  β-Ketoacyl(Cₙ₊₂)-ACP  +  CO₂  +  holo-ACP

Three chemical steps (from PMID: 11502177):

 Step 1 — Transacylation:  Acyl-ACP + Enz-Cys161-SH → Enz-Cys161-S-Acyl + holo-ACP
 Step 2 — Decarboxylation: Malonyl-ACP → (carbanion/enolate)-ACP + CO₂   [His296, His331]
 Step 3 — Condensation:    Enz-S-Acyl + carbanion-ACP → β-ketoacyl-ACP + Enz-Cys161-SH

The β-ketoacyl-ACP product is then processed by the rest of the FAS II ensemble (FabG reductase → FabA/FabZ dehydratase → FabI enoyl reductase) to yield a two-carbon-extended acyl-ACP, which re-enters the cycle.

Where FabB acts in the pathway — the UFA branch point

        Malonyl-ACP  →→ (FabB initiation in P. putida) →→ Acetyl-ACP primer
                                      │
                              elongation cycles
                                      │
             C10 intermediate:  trans-2-decenoyl-ACP
                                      │  FabA (dehydratase/isomerase)
                                      ▼
                          cis-3-decenoyl-ACP  ── committed by ──►  FabB
                                      │        (affinity for cis-decenoyl-ACP)
                                      ▼
                       elongation →→ palmitoleate (16:1), cis-vaccenate (18:1)
                                      │
                                      ▼
                        membrane phospholipids (fluidity control)

FabA creates the cis double bond, but the flux only becomes committed to UFAs when FabB elongates the cis-3-decenoyl-ACP. This makes FabB the gatekeeper of membrane unsaturation, explaining why fabB loss causes UFA auxotrophy in Pseudomonas (PMID: 9286984).

How P. putida FabB differs from E. coli FabB

The bifunctionality (PMID: 38335573) is the standout mechanistic distinction: in P. putida, FabB provides redundancy/robustness to FAS initiation that in E. coli is the exclusive domain of FabH.

Localization

FabB is a soluble cytoplasmic (cytosolic) enzyme (UniProt GO:0005829). FAS II is a dissociated system in which discrete soluble enzymes act on substrates covalently tethered to the small, acidic acyl carrier protein AcpP. FabB therefore does its chemistry in the cytoplasm, handing off phosphopantetheine-linked acyl intermediates via transient, electrostatically guided protein–protein interactions with AcpP (PMID: 31209348). The final acyl-ACP products feed the membrane-associated PlsB/PlsC acyltransferases for phospholipid assembly.

Evidence Base

Consistency of the evidence. All primary sources point to a single coherent picture: FabB is the elongation/UFA-committing condensing enzyme of FAS II, with a conserved Cys-His-His mechanism, operating in the cytoplasm. The Pseudomonas-specific literature (PMID: 9286984, PMID: 38335573) both confirms the conserved UFA role and adds the organism-specific bifunctionality. No source contradicts the assignment; the only discordant note is the automated UniProt "kinase" keyword, which is a recognized annotation artifact.

Limitations and Knowledge Gaps

1. No direct biochemistry on KT2440 Q88FC3 itself. The mechanistic detail (triad function, three-step chemistry, inhibitor binding) is transferred from E. coli FabB by high sequence identity (67.3%) and complete catalytic-residue conservation. The bifunctional initiation activity is experimentally demonstrated in the closely related P. putida F1 strain (~98% identical), not KT2440 directly. Transfer is well justified but remains inference.

2. Substrate-specificity profile not quantified. The preference for cis-3-decenoyl-ACP and the chain-length product distribution (16:1 vs 18:1 ratio) for the P. putida enzyme have not been directly measured here; these are inferred from the conserved UFA-committing role and UniProt's curated (3Z)-decenoyl-ACP reaction.

3. Regulatory circuitry is largely from E. coli. FadR activation and FabR repression of fabB are enterobacterial findings; the exact transcriptional regulators and operon context in P. putida KT2440 (beyond the conserved fabAB linkage seen in P. aeruginosa) were not experimentally established in this investigation.

4. Redundancy with FabF not resolved for KT2440. P. putida likely also encodes a FabF (KAS II). The functional partition between FabB and FabF (e.g., temperature-dependent cis-vaccenate synthesis, which is a classic FabF role in E. coli) was not characterized for KT2440.

5. No experimental structure of the P. putida enzyme. Structural inference rests on homology to E. coli FabB/AcpP complexes.

Proposed Follow-up Experiments / Actions

1. Direct enzymology of recombinant KT2440 FabB. Express and purify Q88FC3; assay condensation with defined acyl-ACP + malonyl-ACP substrates; measure kinetic constants and chain-length/UFA-intermediate preference (especially cis-3-decenoyl-ACP vs saturated decanoyl-ACP) to quantify the UFA-committing specificity.

2. Confirm bifunctional initiation in KT2440. Reproduce the F1 initiation assay (malonyl-ACP decarboxylation → acetyl-ACP → condensation) with the KT2440 enzyme, and test genetic complementation of a FabH-deficient background.

3. Targeted mutagenesis of the predicted triad. Mutate Cys161, His296, His331 (and Asp304/Glu307/Lys326) and confirm the predicted loss of condensation vs decarboxylation activities, directly validating the residue mapping.

4. Inhibitor sensitivity. Test cerulenin and thiolactomycin inhibition of the purified enzyme; introduce the F390-equivalent substitution to verify the TLM-resistance mechanism reported for E. coli (PMID: 11959552) is conserved.

5. Genetics in KT2440. Construct a conditional fabB (PP_4175) mutant and test for UFA auxotrophy and rescue by exogenous oleate/vaccenate; define the fabAB operon structure and regulator binding (FadR/FabR homologs) by RNA-seq and promoter analysis.

6. Correct the database annotation. Flag/curate out the spurious "Kinase"/"ATP-binding" (GO:0016301, GO:0005524) keywords on UniProt Q88FC3, which conflict with the enzyme's true condensing-enzyme function.

7. Structural work. Determine a crystal or cryo-EM structure of KT2440 FabB, ideally in complex with AcpP, to compare the substrate-gating loop and confirm the basis of cis-decenoyl-ACP selectivity.